BioSpace News Archive

Business

Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases

Ionis Pharmaceuticals, Inc. announced that it closed its expanded strategic collaboration with Biogen to discover and develop novel antisense drugs for a broad range of neurological diseases following receipt of clearance under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976.

June 5, 2018
·
4 min read
Biotech Bay

Revance to Participate in Upcoming Investor Conferences this June 2018

Revance Therapeutics, Inc. announced that the Company will participate in two upcoming investor conferences.

June 5, 2018
·
1 min read
Business

Vytalyx Appoints Dave Wentz, Former CEO of USANA to its Board of Directors

New Board Member Brings Decades of Experience Across Health Products, Nutritional Supplements, Manufacturing, And Direct Sales to Start-Up Health Technology Company

June 5, 2018
·
1 min read
Deals

ImmunoGen Announces Proposed Public Offering of 12,000,000 Shares of Common Stock

ImmunoGen, Inc. announced that it intends to offer and sell, subject to market and other conditions, 12,000,000 shares of its common stock in an underwritten public offering.

June 5, 2018
·
4 min read
Biotech Beach

Exelixis to Present at the William Blair & Co. 38th Annual Growth Stock Conference on June 12, 2018

Exelixis, Inc. announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide an overview of the company at the William Blair 2018 Growth Stock Conference

June 5, 2018
·
2 min read
Pharm Country

Alexion to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

Alexion Pharmaceuticals announced that management will present at the Goldman Sachs 39th Annual Global Healthcare Conference

June 5, 2018
·
1 min read
Biotech Beach

NuVasive To Present At The Goldman Sachs Annual Global Healthcare Conference

NuVasive, Inc. announced that management will present at the Goldman Sachs 39th Annual Global Healthcare Conference

June 5, 2018
·
2 min read
Drug Development

Ironwood Pharmaceuticals Presents IW-3718 Data Showing Improvements in Heartburn and Regurgitation Symptoms

Ironwood presented data from a double-blind, placebo-controlled, dose-ranging Phase IIb trial evaluating IW-3718 in persistent gastroesophageal reflux disease (GERD) during a distinguished abstract plenary oral session at Digestive Disease Week® (DDW) 2018 in Washington, D.C.

June 5, 2018
·
10 min read
Biotech Beach

Quidel to Present at William Blair 38th Annual Growth Stock Conference

Quidel Corporation announced that it will present at the William Blair 38th Annual Growth Stock Conference at the Four Seasons hotel in Chicago, Illinois on Tuesday, June 12, 2018.

June 5, 2018
·
2 min read
Drug Development

Tenax Therapeutics Announces Appointment of Anthony A. DiTonno as CEO

Tenax Therapeutics, Inc. today announced the Company has selected board member Anthony A. DiTonno to be its next Chief Executive Officer, effective June 1, 2018.

June 5, 2018
·
4 min read